Provided by Tiger Trade Technology Pte. Ltd.

NeoGenomics

16.02
+0.05000.31%
Post-market: 15.96-0.0600-0.37%19:30 EDT
Volume:3.52M
Turnover:55.50M
Market Cap:2.05B
PE:-39.83
High:16.09
Open:15.72
Low:15.41
Close:15.97
52wk High:20.15
52wk Low:7.07
Shares:128.00M
Float Shares:117.00M
Volume Ratio:1.16
T/O Rate:3.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4023
EPS(LYR):-0.8433
ROE:-6.33%
ROA:-1.89%
PB:2.61
PE(LYR):-19.00

Loading ...

Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and NeoGenomics (NEO)

TIPRANKS
·
Yesterday

Neogenomics, Inc. : Bofa Global Research Raises Price Objective to $20 from $16

THOMSON REUTERS
·
Oct 07

NeoGenomics (NEO) Could Be 3% Overvalued After Guidance And CEO Change

Simply Wall St.
·
Oct 07

NeoGenomics on 'More Solid Footing' With Strong Revenue Growth, Needham Says

MT Newswires Live
·
Oct 07

NeoGenomics price target raised to $20 from $16 at StoneX

TIPRANKS
·
Oct 06

NeoGenomics Rises After BTIG Upgrades to 'buy'

Reuters
·
Oct 06

StoneX Sticks to Their Buy Rating for NeoGenomics (NEO)

TIPRANKS
·
Oct 06

BTIG Upgrades NeoGenomics to Buy From Neutral, Price Target is $28

MT Newswires Live
·
Oct 06

Neogenomics, Inc. : StoneX Raises Target Price to $20 from $16

THOMSON REUTERS
·
Oct 06

NeoGenomics Price Target Announced at $28.00/Share by BTIG

Dow Jones
·
Oct 06

Stocks to Watch: Standard BioTools, NeoGenomics, Pinterest

Dow Jones
·
Oct 06

NeoGenomics down 2% at $18.73 after Q3 pre-announcement, CEO transition

TIPRANKS
·
Oct 06

NeoGenomics Expects to Increase FY Rev Guidance

Dow Jones
·
Oct 06

NeoGenomics Lines up CEO Succession

Dow Jones
·
Oct 06

NeoGenomics Names Warren Stone CEO Effective Jan. 4, 2027

Reuters
·
Oct 06

Neogenomics, - Tony Zook to Become Executive Chairman Effective January 4, 2027

THOMSON REUTERS
·
Oct 06

Neogenomics, - Appoints Michael Kelly as Lead Independent Director Effective January 4, 2027

THOMSON REUTERS
·
Oct 06

Neogenomics, - Full-Year Total Revenue Guidance Expected to Increase at Midpoint

THOMSON REUTERS
·
Oct 06

Neogenomics, - Preliminary Q3 Revenue Expected at $209 Mln; Ngs Revenue Growth About 28%

THOMSON REUTERS
·
Oct 06

Neogenomics, - Appoints Warren Stone as CEO and Board Member Effective January 4, 2027

THOMSON REUTERS
·
Oct 06